TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data

Gavin Ha, Andrew Roth, Jaswinder Khattra, +18

Genome Research

Clonal Cell PopulationsEngineeringCopy Number ArchitecturesGeneticsGenomics +17

Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes

Jonathan T. Sockolosky, Eleonora Trotta, Giulia Parisi, +15

Science

Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy

Akanksha Chhabra, Aaron M. Ring, Kipp Weiskopf, +10

Science Translational Medicine

Cell TherapyHsc TransplantationImmunologyPathologyImmunotherapy +14

Cytogenetic Abnormalities in Primary Myelodysplastic Syndrome Are Highly Predictive of Outcome After Allogeneic Bone Marrow Transplantation

Thomas J. Nevill, Henry C. Fung, John D. Shepherd, +11

Blood

Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness

Matthew D. Seftel, Gershon H. Growe, Tanya Petraszko, +7

Blood

Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience

INM Micallef, Mukesh Chhanabhai, RD Gascoyne, +8

Bone Marrow Transplantation

TransplantationMarrow TransplantationStem Cell TransplantationImmunologyHematology +7

Mucosal production of uric acid by airway epithelial cells contributes to particulate matter-induced allergic sensitization

Matthew J. Gold, Paul Hiebert, H Y Park, +16

Mucosal Immunology

InflammationEnvironmental AllergyAllergyInflammatory Lung DiseaseLung Inflammation +9

Antibody Conditioning Enables MHC-Mismatched Hematopoietic Stem Cell Transplants and Organ Graft Tolerance

Benson M. George, Kevin S. Kao, Hye‐Sook Kwon, +11

Cell stem cell

HistocompatibilityTransplant RejectionCell TherapyTransplantationAutoimmune Disease +13

Audit of the frequency and clinical response to excessive oral anticoagulation in an out-patient population

Malcolm L. Brigden, Christina Kay, Alan Le, +2

American Journal of Hematology

Out-patient PopulationPharmacotherapyThrombosisLarge Outpatient LaboratoryVenous Thrombosis +18

Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis

Donna L. Forrest, Thomas J. Nevill, Sheldon C. Naiman, +11

Bone Marrow Transplantation

Cell TherapyRisk Factor AnalysisTransplantationMarrow TransplantationOncology +8